Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-100
SponsorPOCHIWU

About this trial

The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).

Study Objectives:

To assess whether Qi-Gong improves physiological function in individuals with PASC.

To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.

Study Design:

If a comparison group is included, researchers will compare Qi-Gong with standard care to assess its effectiveness.

Participant Involvement:

Practice Qi-Gong three times per week for three months. Record physiological data monthly.

Eligibility criteria

Qualifiers

PASC

above 20 y/o

Disqualifiers

Those who cannot cooperate

Severe schizophrenia

Trial design

Treatments tested in this trial

  • QI-GONG and control

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

POCHIWU

Lead sponsor

National Taipei University of Nursing and Health Sciences

Sponsor institution